Gary D. Tollefson, President and CEO at Orexigen Therapeutics, Inc. (OREX), sold 15,000 shares at $14.30 ($214K) on 2007-12-17, disclosed to the SEC on 2007-12-19.
Scheduled sale ($214k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.15 | 1,000 | $14K | 6.6% |
| 2 | $14.25 | 1,000 | $14K | 6.7% |
| 3 | $14.26 | 3,000 | $43K | 20.0% |
| 4 | $14.27 | 4,000 | $57K | 26.6% |
| 5 | $14.29 | 1,000 | $14K | 6.7% |
| 6 | $14.30 | 1,000 |
| $14K |
| 6.7% |
| 7 | $14.33 | 2,000 | $29K | 13.4% |
| 8 | $14.34 | 1,000 | $14K | 6.7% |
| 9 | $14.35 | 1,000 | $14K | 6.7% |
| Total | $14.28 avg | 15,000 | $214K | 100% |
| Filing → |